|
Hepatic Veins
|
D006503 |
[Veins which drain the liver.
] |
|
Hepatic Veno-Occlusive Disease
|
D006504 |
[Liver disease that is caused by injuries to the ENDOTHELIAL CELLS of the vessels and subendothelial EDEMA, but not by THROMBOSIS. Extracellular matrix, rich in FIBRONECTINS, is usually deposited around the HEPATIC VEINS leading to venous outflow occlusion and sinusoidal obstruction.
] |
|
Hepatitis
|
D006505 |
[INFLAMMATION of the LIVER.
] |
|
Hepatitis A
|
D006506 |
[INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.
] |
|
Hepatitis A Antibodies
|
D035922 |
[Antibodies to the HEPATITIS A ANTIGENS including antibodies to envelope, core, and non-structural proteins.
] |
|
Hepatitis A Antigens
|
D035921 |
[Antigens produced by various strains of HEPATITIS A VIRUS such as the human hepatitis A virus (HEPATITIS A VIRUS, HUMAN).
] |
|
Hepatitis A Vaccines
|
D022362 |
[Vaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS).
] |
|
Hepatitis A Virus Cellular Receptor 1
|
D000072596 |
[An Ig domain-containing membrane receptor for HEPATITIS A VIRUS; EBOLA VIRUS; MARBURG VIRUS; and DENGUE VIRUS. It may also function to modulate ASTHMA and HYPERSENSITIVITY.
] |
|
Hepatitis A Virus Cellular Receptor 2
|
D000072597 |
[An Ig domain-containing membrane receptor that is expressed by TH1 CELLS. It regulates the activation of MACROPHAGES and inhibits TH1-mediated auto- and alloimmune responses to promote IMMUNE TOLERANCE.
] |
|
Hepatitis A Virus, Human
|
D017957 |
[A strain of HEPATITIS A VIRUS which causes hepatitis in humans. The virus replicates in hepatocytes and is presumed to reach the intestine via the bile duct. Transmission occurs by the fecal-oral route.
] |
|
Hepatitis A virus
|
D030041 |
[A species in the genus HEPATOVIRUS containing one serotype and two strains: HUMAN HEPATITIS A VIRUS and Simian hepatitis A virus causing hepatitis in humans (HEPATITIS A) and primates, respectively.
] |
|
Hepatitis Antibodies
|
D006508 |
[Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis.
] |
|
Hepatitis Antigens
|
D018963 |
[Antigens from any of the hepatitis viruses including surface, core, and other associated antigens.
] |
|
Hepatitis B
|
D006509 |
[INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
] |
|
Hepatitis B Antibodies
|
D006510 |
[Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens.
] |
|
Hepatitis B Antigens
|
D006511 |
[Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS.
] |
|
Hepatitis B Core Antigens
|
D006512 |
[The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion.
] |
|
Hepatitis B Surface Antigens
|
D006514 |
[Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.
] |
|
Hepatitis B Vaccines
|
D017325 |
[Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced.
] |
|
Hepatitis B Virus, Duck
|
D015611 |
[A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected ducks.
] |
